Data-Driven Insights

Silicon Valley high-flyer DocuSign publishes data on the race and ethnicity of its employees and senior leaders, information that isn’t always flattering. Brunswick spoke with DocuSign’s Chief People Officer on its commitment to transparency.

The pharmaceutical industry is seizing the moment to both help lift society out of the pandemic and rebuild its own reputation. The clock is ticking. By Brunswick’s Ben Hirschler and Jeremy Ruch.

Most women report feeling unsafe while running. A new nonprofit wants to help fix that.

Brunswick Insight’s poll of employees reveals how they would like their companies to respond. By Mara Riemer.

ESG analysis is establishing itself as core business practice despite entrenched efforts to dismiss it, say Brunswick’s Dan Lambeth & Kanhai Parasharya.

New Brunswick research on what the public took away from the historic climate conference.

Helen Krause, Managing Director, Head of Global Data Insights at Citi, talks to Brunswick’s Stacey Chow about fintech collaborations and using AI to foster transparency.

Will AI drive a revolution in drug discovery? Ben Hirschler examines how it is being used to sift through a mountain of health-related data—including his own biomedical records.

Brunswick Insight’s Zayd Mabruk reports.

Yes—but maybe not. It’s complicated. Scott Foster reports.

After decades of neglect, it’s time to recognize that investing in women’s health is the right and smart thing to do. Ben Hirschler and Charis Gresser report.